-transparent.png){kind=logo}
Twenty-seven substituted benzoic acids have been studied as inhibitors of partially purified human renal thiopurine methyltransferase (TPMT). Quantitative structure-activity relationship (QSAR) analysis resulted in the following equation: pI50 = 1.25( +/- 0.53)pi'3 + 0.73( +/- 0.38)MR3,4 + 2.92( +/- 0.39). In this equation pI50 is the -log of the concentration of compound that inhibits the enzyme activity by 50% (IC50);pi'3 is the relative hydrophobicity of the more hydrophobic of the two meta substituents; and MR3,4 is the molar refractivity of the more hydrophobic of the two meta substituents and of the para substituent on the phenyl ring. In addition, 14 substituted thiophenols were tested as substrates for the enzyme. All 14 thiophenols tested were excellent substrates with Km constants (0.8-7.8 microM) that were at least 2 orders of magnitude lower than those of any known thiopurine substrate for TPMT. However, there was no discernible relationship between the activities of thiophenol substrates and their physicochemical parameters. These results suggest that benzoic acid inhibitors of and thiophenol substrates for TPMT may interact with different sites on the enzyme.
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
November 1994,
Biochemical pharmacology,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
August 2022,
Journal of medicinal chemistry,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
December 1971,
Biochemistry,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
June 2006,
Zhonghua zhong liu za zhi [Chinese journal of oncology],
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
April 1975,
Biochemical pharmacology,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
October 1996,
Pharmaceutical research,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
June 2002,
The New Zealand medical journal,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
December 2010,
Journal of enzyme inhibition and medicinal chemistry,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
June 1992,
Journal of computer-aided molecular design,
M M Ames, and
C D Selassie, and
L C Woodson, and
J A Van Loon, and
C Hansch, and
R M Weinshilboum
July 2020,
Crohn's & colitis 360,
